Injective launches pre-IPO market for Anthropic ahead of Nasdaq debut

Injective has introduced a pre-IPO market for Anthropic, offering investors early access to the AI company's equity before its public debut on Nasdaq. Anthropic is preparing to launch its initial public offering with an expected date of November 19, 2026, offering 825 million shares priced between $70 to $78, potentially reaching a valuation between $1.25 trillion and $1.45 trillion.

The introduction of the pre-IPO market on Injective reflects significant interest in Anthropic's upcoming market entry. Market participants anticipate that the IPO will test public interest in AI sector investments, as Anthropic was last privately valued at approximately $965 billion.

Market Confidence

Current market data indicates strong support for a November 19 IPO date, with a 93.3% YES pricing, while earlier dates show negligible support. Predictions regarding Anthropic's market capitalization upon IPO close suggest that market participants expect a valuation within the proposed range, with a 43.5% chance of achieving a market cap between $1.25 trillion and $1.5 trillion.

Key Developments

Attention will be on regulatory approvals, including the SEC's review of Anthropic's registration statement, which could confirm the November 19 date. Market participants will also monitor underwriter reports and any potential adjustments to the IPO pricing or size, which could influence market sentiment.

Additionally, any developments in the broader AI sector or changes in market conditions may impact Anthropic's valuation and interest leading up to the IPO.